Status: Recruiting
Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma
To evaluate the efficacy of citicoline eye drops 2% in reducing visual field deterioration in patients with progressing OAG treated according to best clinical practice. Secondary objectives are assessing the effect of citicoline eye drops 2% on changes in structural parameters measured by Spectral Domain Optical Coherence Tomography (SD-OCT) and evaluating the safety of citicoline eye drops 2%
Participants needed: 1,000
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Omikron Italia S.r.l.Updated: Mar 12, 2024Locations: 1
Eligibility criteria
Signed written informed consent. [+8]
Cataract in the study eye which, in the opinion of the clinician, may require ca... [+9]